Presenting InVera™, the world's first medical device to utilise the body's biological response to treat varicose veins and venous ulcers without harmful side effects

InVera™

A Major Breakthrough in Venous Disease Treatment

We are developing InVera™ – a less invasive, effective, pain free, and a faster minimally invasive endovenous medical device treatment for all chronic venous disease patients.

InVera™ is the world’s first effective non-thermal medical device to treat varicose veins and venous ulcers, collectively known as chronic venous disease*, without harmful side effects. InVera™ uses the body’s natural healing response to treat symptoms allowing all chronic venous disease sufferers receive treatment for the first time.

* – This device is currently for Investigational Research Use Only. We are working towards US & EU regulatory approval.

Watch Video

Play Video

Chronic Venous Disease

Chronic Venous disease (CVD) occurs when blood is not circulated effectively around the body. It is caused by the failure of one-way valves responsible for preventing blood flowing backwards in veins and results in blood pooling in the legs. Chronic Venous Disease is a progressive spectrum of symptoms where 5% of sufferers experience more advanced symptoms every year.

Symptoms begin with varicose veins, which are dilated, tortuous veins. This can progress to pain, heaviness and leg swelling, eczema and subsequent skin changes leading to the breakdown of the skin, and malodorous leaking venous ulceration, in addition to cosmetic dissatisfaction.

This is a progressive and devastating disease which destroys quality of life for patients who experience advanced symptoms.

Watch Video

Play Video

A Huge Underestimated Healthcare Need

Venous disease affects one in four people and ranks as the 4th most common chronic disease in the world. This progressive venous disease culminates in debilitating venous leg ulcers that destroy quality of life for sufferers. It places a huge burden on health care systems, representing up to 3% of total healthcare budgets of western countries.

Only 1.3% of the 120 million people in the US & Europe who suffer from venous disease currently receive treatment each year.

Our device offers an unrivalled lower risk treatment which will allow more patients who suffer from venous disease to access effective treatment*.

* – This device is currently for Investigational Research Use Only. We are currently working towards US & EU regulatory approval.

Watch Video

Play Video

Meet The InVera Medical Leadership Team

Stephen Cox

CEO & Co-Founder

Nigel Phelan

CMO & Co-Founder

Sean Cummins

CTO & Co-Founder

Aisling O'Sullivan

Vice President for Quality Assurance and Regulatory Affairs

Our team is growing.

Join us to bring our innovative mechanical endovenous medical device for the treatment of Chronic Venous Disease to the market. Let’s build.

We seek talented people, who will lead and innovate to make a positive impact in a fast-paced patient-focused environment.

Our Values are important. We’re always interested to hear from people who share them:

Patient First

A commitment to delivery of safe and effective solutions that improve the quality of life of our patients.

High-Quality Customers Delivery

To deliver a high-quality sustainable product and service to our customers at a reasonable price.

Purposeful Innovation

To use scientific research to further develop the understanding of unmet clinical needs to benefit patients.

Employee Enrichment

To provide a respectful environment where employees can thrive with calculated bias for action.

Strong Shareholder Position

To achieve strong returns and positive cash position to swiftly capitalise on future opportunities.

Contact the InVera Medical™ team at info@inveramedical.com

InVera Medical™ is an equal opportunities employer.

InVera Medical Announced as Presenting Company at LSI Emerging Medtech Summit USA 2024

InVera Medical Announces Promotion of Dr. Aisling O’Sullivan to Vice President for Quality Assurance and Regulatory Affairs

InVera Medical Seizes Momentum at JPM Healthcare Conference 2024, Anticipating a Year of Healthcare Transformation

InVera Medical Launches Groundbreaking €4.6 million BioVAS DTIF Project: Pioneering Advances in Microvascular Vessel Intervention for Venous Leg Ulceration.

Exciting News from InVera Medical at VEITH Symposium!

InVera Medical feature in the latest American Venous Forum | AVF Vein Specialist Newsletter on Emerging Technology Read More

Key Opinion Leader Lowell Kabnick MD presents InVera Medical’s latest updates during the Emerging Technology and Global Abstracts sessions at UIP 2023.

InVera Medical present at LSI Europe 23 Read More

InVera Medical named among Ireland’s breakthrough medical and life sciences innovators. Read More

InVera Medical awarded ISO 13485:2016 certification by BSI for the design, development, and manufacture of sterile ablation catheters for chronic venous disease.

InVera Medical CEO Stephen Cox joins “The Future of Medtech” panel at MedTech Strategist Innovation Summit Dublin 2023

InVera Medical CEO, Stephen Cox presents at LSI USA (March 2023) Watch Stephen's Pitch Back here

InVera Medical announced as a Finalist for Emerging Medtech Company of the Year Award as part of the Irish Medtech Awards 2022 Read More

InVera Medical named among 15 start-ups in Europe shaking up the future of healthcare Read More

InVera Medical targets €17m ‘game-changer’ funding for device to treat varicose veins (Business Post, Aug 2022) Read More

InVera Medical among four Irish companies funded from highly competitive Horizon Europe EIC accelerator Read More

Venari Medical announces publication of pre-clinical data in leading scientific journal Phlebology and changes name to InVera Medical™

InVera Medical™: Galway medtech with a potentially life-changing device (Silicon Republic, May 2021) Read More

InVera Medical™ secures $5.3 million investment to advance the Minimally Invasive Treatment of Chronic Venous Disease